[1] [1] JOSHI S S, BADGWELL B D. Current treatment and recent progress in gastric cancer ［J］. CA: A Cancer Journal for Clinicians, 2021, 71(3): 264-279.

[2] [2] CHAO J, FUCHS C S, SHITARA K, et al. Assessment of pembrolizumab therapy for the treatment of microsatellite instability-high gastric or gastroesophageal junction cancer among patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 clinical trials ［J］. JAMA Oncology, 2021, 7(6): 895-902.

[3] [3] OAKES S A, PAPA F R. The role of endoplasmic reticulum stress in human pathology ［J］. Annual Review of Pathology, 2015, 10(1): 173-194.

[4] [4] LEE A S, HENDERSHOT L M. ER stress and cancer ［J］. Cancer Biology & Therapy, 2006, 5(7): 721-722.

[5] [5] SHUDA M, KONDOH N, IMAZEKI N, et al. Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis ［J］. Journal of Hepatology, 2003, 38(5): 605-614.

[6] [6] ZHU P, XUE J, ZHANG Z J, et al. Helicobacter pylori VacA induces autophagic cell death in gastric epithelial cells via the endoplasmic reticulum stress pathway ［J］. Cell Death & Disease, 2017, 8(12): 3207.

[7] [7] ZHENG H C, GONG B C, ZHAO S. The meta and bioinformatics analysis of GRP78 expression in gastric cancer ［J］. Oncotarget, 2017, 8(42): 73017-73028.

[8] [8] LIMIA C M, SAUZAY C, URRA H, et al. Emerging roles of the endoplasmic reticulum associated unfolded protein response in cancer cell migration and invasion ［J］. Cancers (Basel), 2019, 11(5): 631.

[9] [9] WILKERSON M D, HAYES D N. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking ［J］. Bioinformatics, 2010, 26(12): 1572-1573.

[10] [10] FINOTELLO F, MAYER C, PLATTNER C, et al. Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data ［J］. Genome Medicine, 2019, 11(1): 34.

[11] [11] CHEN X, CUBILLOS-RUIZ J R. Endoplasmic reticulum stress signals in the tumour and its microenvironment ［J］. Nature Reviews Cancer, 2021, 21(2): 71-88.

[12] [12] HUANG R, LI G, WANG K, et al. Comprehensive analysis of the clinical and biological significances of endoplasmic reticulum stress in diffuse gliomas ［J］. Frontiers in Cell and Developmental Biology, 2021, 9: 619396.

[13] [13] GILSBACH B K, KORTHOLT A. Structural biology of the LRRK2 GTPase and kinase domains: implications for regulation ［J］. Frontiers in Aolecular Neuroscience, 2014, 7: 32.

[14] [14] MADERO-PéREZ J, FDEZ E, FERNáNDEZ B, et al. Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation ［J］. Molecular Neurodegeneration, 2018, 13(1): 3.

[15] [15] YANG Y, LIU L, NAIK I, et al. Transcription factor C/EBP homologous protein in health and diseases ［J］. Frontiers in Immunology, 2017, 8: 1612.

[16] [16] LIN H, LIU S, GAO W, et al. DDIT3 modulates cancer stemness in gastric cancer by directly regulating CEBPβ ［J］. The Journal of Pharmacy and Pharmacology, 2020, 72(6): 807-815.

[17] [17] LIU S, ZHAO Y, XU Y, et al. The clinical significance of methylation of MAGE-A1 and -A3 promoters and expression of DNA methyltransferase in patients with laryngeal squamous cell carcinoma ［J］. American Journal of Otolaryngology, 2020, 41(1): 102318.

[18] [18] JI Y, TU X, HU X, et al. The role and mechanism of action of RNF186 in colorectal cancer through negative regulation of NF-κB ［J］. Cellular Signalling, 2020, 75: 109764.

[19] [19] SHRESTHA S, BYRNE D P, HARRIS J A, et al. Cataloguing the dead: breathing new life into pseudokinase research ［J］. The FEBS Journal, 2020, 287(19): 4150-4169.

[20] [20] HUANG J, TENG L, LIU T, et al. Identification of a novel serine/threonine kinase that inhibits TNF-induced NF-kappa B activation and p53-induced transcription ［J］. Biochemical and Biophysical Research Communications, 2003, 309(4): 774-778.

[21] [21] DU K, HERZIG S, KULKARNI R N, et al. TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver ［J］. Science, 2003, 300(5625): 1574-1577.

[22] [22] ZHANG L, LU Z, ZHAO X. Targeting Bcl-2 for cancer therapy ［J］. Biochim Biophys Acta Rev Cancer, 2021, 1876(1): 188569.

[23] [23] WANG B, XIE Y, ZHENG L, et al. Both the serum AFP test and AFP/GPC3/SALL4 immunohistochemistry are beneficial for predicting the prognosis of gastric adenocarcinoma ［J］. BMC Gastroenterology, 2021, 21(1): 408.

[24] [24] WU X, QU D, WEYGANT N, et al. Cancer stem cell marker DCLK1 correlates with tumorigenic immune infiltrates in the colon and gastric adenocarcinoma microenvironments ［J］. Cancers, 2020, 12(2): 274.

[25] [25] WANG T, QIN Y, LAI H, et al. The prognostic value of ADRA1 subfamily genes in gastric carcinoma ［J］. Oncology Letters, 2019, 18(3): 3150-3158.

[26] [26] ZENG Z, XIE D, GONG J. Genome-wide identification of CpG island methylator phenotype related gene signature as a novel prognostic biomarker of gastric cancer ［J］. PeerJ, 2020, 8: e9624.

[27] [27] CHEN Z, LIU B, YI M, et al. A prognostic nomogram model based on mRNA expression of DNA methylation-driven genes for gastric gancer ［J］. Frontiers in Oncology, 2020, 10: 584733.